Clinical Trial Update: Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cetuximab in combination with irinotecan, oxaliplatin, and tegafur-uracil (UFT) for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)
• UFToral (tegafur-uracil)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED